Frontline combination of dasatinib and low-intensity chemotherapy in adults with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia.
Yizhou PengJinjin HuangJin YinFankai MengYang CaoLiang HuangDengju LiYicheng ZhangDonghua ZhangLi MengZhiqiang HanZhenya HongPublished in: Expert review of hematology (2024)
The trial was registered at ClinicalTrials.gov as NCT02690922.
Keyphrases
- acute lymphoblastic leukemia
- phase iii
- allogeneic hematopoietic stem cell transplantation
- study protocol
- phase ii
- locally advanced
- clinical trial
- chronic myeloid leukemia
- copy number
- randomized controlled trial
- squamous cell carcinoma
- rectal cancer
- radiation therapy
- chemotherapy induced
- acute myeloid leukemia
- dna methylation
- gene expression